Because of this, any consideration of BPC-157 should happen with a licensed provider who can explain where things currently stand and what your options are
Griesinger G, Franke K, Kinast C, Kutzelnigg A, Riedinger S, Kulin S, et al
S.ParkI
Thats where a new wave of oral GLP-1 medications could make a difference
In stroke, reduced mitophagy and autophagy may hinder the prompt clearance of damaged mitochondria in the brain, leading to a loss of protection from increased reactive oxygen species (ROS) and reduced mitochondrial ATP supply (Frugier et al., 2015)
In comparison, acetyl l carnitine by itself stimulates such growth by "only" 5.6%, while a combination of acetyl l carnitine and l arginine taken separately achieves a growth rate of 5.2%